The UK Government has announced its new Drug Strategy 2017. Building on similar themes as the previous strategy, its main impact will be longer follow up rates for what constitutes recovery from 6 to 12 months. To read the strategy click here. A number of commentators have criticized the new policy, for a review click here. Along side this are also new clinical guidelines for prescribing-known as the Orange book (here)-and a new framework the new Psychoactive Review Framework (here).